11/18/2025 03:00
Ant International Deepens Participation in Project Ensemble as New Architecture Community Member

Ant International today announced it has joined Project Ensemble’s Architecture Community to support the design and advancement of Hong Kong’s tokenisation ecosystem. As a Community member, it will be more involved in defining industry standards and supporting the development of Hong Kong’s tokenisation market, together with the Hong Kong Monetary Authority (HKMA) and leading peers. A fintech representative on the Community, Ant International will also contribute its technological and innovatio...

AFP partners with Québec’s Laval University to enrich training of future journalists

Agence France-Presse (AFP) and Québec’s Laval University today signed a partnership agreement under which AFP pledged to host trainee journalists at bureaux within its international network and contribute to the University’s journalism courses.

Agence France-Presse (AFP) and Québec’s Laval University today signed a partnership agreement under which AFP pledged to host trainee journalists at bureaux within its international network and contribute to the University’s journalism courses.
Anglais
11/18/2025 03:05
Omdia: Southeast Asia smartphone shipments slip 1% in 3Q25 as vendors face mounting cost pressures

Latest research from Omdia shows that the Southeast Asia’s smartphone market declined 1% in 3Q25, with shipments totaling 25.6 million units - the third consecutive quarter of year-on-year contraction. Samsung led the region with 4.6 million units and an 18% share, driven by its premium-leaning portfolio in higher-ASP markets such as Thailand, Vietnam and Malaysia. This helped offset competitors’ gains in more price-sensitive markets like Indonesia and the Philippines. TRANSSION followed close ...

11/18/2025 02:51
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg

The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled syringe (PFS). The European Commission (EC) approved Omlyclo™ 75 mg/0.5ml and 150mg/1ml solution for injection in pre-filled syringe in May 2024. Omlyclo™ is indicated for the treatment of patients with allergic asthma, chronic spontaneous urticaria (CSU) and chronic rhinosinusitis with nasal pol...

French war reporter who witnessed Lee Harvey Oswald shooting dies aged 94

A veteran French war reporter who was a witness in Dallas to the fatal shooting of Lee Harvey Oswald has died at the age of 94, his family said on Sunday.

A veteran French war reporter who was a witness in Dallas to the fatal shooting of Lee Harvey Oswald has died at the age of 94, his family said on Sunday.
11/25/2025 07:00
Friendly Fraud Expected to Increase by 25% Between Thanksgiving and Cyber Monday, Warns ACI Worldwide

'Friendly fraud’ is expected to increase by 25% between Thanksgiving and Cyber Monday, according to an analysis of billions of transactions of global eCommerce businesses by ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology. ‘Friendly fraud’ or ‘return fraud’ occurs when legitimate customers dispute transactions post-purchase. Often mistaken for true fraud, these disputes are a growing industry challenge and cost retailers $103 billion in 2024 alone, according t...

11/25/2025 07:00
GigaDevice Launches GD25NX Series xSPI NOR Flash with Dual-Voltage Design

GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced the launch of its new generation of high-performance dual-voltage xSPI NOR Flash products – the GD25NX series. Featuring a 1.8 V core and 1.2 V I/O design, the GD25NX series connects directly to 1.2 V system on chips (SoCs) without an external booster circuit, significantly reducing system power consumption and BOM cost. This press release featu...